샘플 요청 목록

 카트 문의
시장보고서
상품코드
1577497

세계의 노인용 의약품 시장

Geriatric Medicines
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 304 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 노인용 의약품 시장은 2030년까지 2,225억 달러에 달할 것으로 전망

2023년 1,532억 달러로 추정되는 세계 노인용 의약품 시장은 2023-2030년 동안 연평균 5.5% 성장하여 2030년에는 2,225억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 항고혈압제는 CAGR 6.8%를 기록하여 분석 기간 종료 시점에 499억 달러에 도달할 것으로 예상됩니다. 진통제 부문은 분석 기간 동안 CAGR 5.7%의 성장률을 기록할 것으로 추정됩니다.

미국 시장 417억 달러로 추정, 중국은 CAGR 9.1%로 성장 전망

미국의 노인용 의약품 시장 규모는 2023년 417억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 472억 달러의 시장 규모에 도달할 것으로 예상되며, 2023-2030년 분석 기간 동안 9.1%의 CAGR을 기록할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.1%와 5.6%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 연평균 3.4%의 성장률을 보일 것으로 예상됩니다.

세계 노인용 의약품 시장 - 주요 동향 및 촉진요인 정리

노인용 의약품이란 무엇이며, 왜 고령화 사회에 필수적인가?

노인용 의약품은 고령 환자가 직면한 독특한 건강 문제를 해결하기 위해 고안된 특수 의약품입니다. 노년층은 고혈압, 당뇨병, 관절염, 인지장애 등 만성질환과 같은 여러 가지 건강 문제에 직면하는 경우가 많으며, 이를 치료하기 위해서는 다학제적 접근이 필요합니다. 노인용 의약품은 특히 이러한 계층을 대상으로 노인에게 많이 나타나는 증상에 초점을 맞추고 생리적, 대사적 요구에 더 적합한 치료법을 제공합니다. 이러한 의약품은 질병 관리에 대처할 뿐만 아니라 치료가 부작용과 다른 의약품과의 상호 작용을 최소화하여 노인의 전반적인 삶의 질을 향상시킬 수 있도록 보장합니다. 선진국을 중심으로 세계 인구의 고령화가 빠르게 진행됨에 따라 신흥국의 의약품 수요는 지속적으로 증가하고 있으며, 이는 헬스케어 산업에서 매우 중요한 분야로 부상하고 있습니다.

의약품의 발전은 노인의학 발전을 어떻게 형성하고 있는가?

의약품 연구개발의 발전은 보다 효과적이고 안전한 노인용 의약품 개발에 큰 영향을 미치고 있습니다. 혁신의 주요 분야 중 하나는 노인 특유의 건강 상태와 노화에 따른 다발성 약화 문제를 고려하여 노인 특유의 요구에 맞는 맞춤형 의약품을 개발하는 것입니다. 노인들이 직면한 복약순응도 문제를 해결하기 위해 서방형 제제, 병용요법, 패치 및 용해정 등 복용이 용이한 약물이 개발되고 있습니다. 또한, 바이오테크놀러지는 알츠하이머병, 골다공증, 심혈관질환 등 노년층에서 많이 발생하는 질환에 대한 표적 치료제를 개발하는 데 중요한 역할을 하고 있습니다. 이러한 발전은 치료 결과를 개선할 뿐만 아니라 약물 상호 작용과 부작용의 위험을 줄여 노인이 보다 효과적으로 질병을 관리할 수 있도록 돕습니다.

인구의 변화와 의료 시스템의 변화가 노인용 의약품 수요를 견인하는 이유는 무엇일까?

세계 인구의 고령화는 노인용 의약품의 수요를 크게 견인하고 있습니다. 평균 수명이 연장됨에 따라 특히 북미, 유럽, 동아시아 등의 지역에서 노인 인구의 비율이 빠르게 증가하고 있습니다. 이러한 인구통계학적 변화로 인해 의료 시스템은 노인들에게 적절한 의료 서비스를 제공하는 것이 시급한 과제가 되고 있습니다. 각국 정부와 의료 서비스 제공자들은 노인 의료에 대한 투자를 늘리고 있으며, 예방과 노화에 따른 만성질환 관리에 중점을 두고 있습니다. 또한, 신흥 시장에서는 의료 인프라가 개선됨에 따라 노인 의료에 대한 접근성이 확대되고 전문 의약품에 대한 수요가 더욱 증가하고 있습니다. 노화와 관련된 건강 상태에 대한 대중의 인식이 높아지면서 치매, 관절염, 심혈관질환 등의 조기 진단 및 치료 옵션에 대한 수요도 증가하고 있습니다. 노인의료에 대한 관심이 높아짐에 따라 의료 환경이 변화하고 있으며, 노인의료가 의료서비스 제공자와 제약회사들의 우선순위로 떠오르고 있습니다.

세계 노인용 의약품 시장 성장의 원동력은?

세계 노인용 의약품 시장의 성장은 의약품 개발의 발전, 세계 인구의 고령화, 헬스케어 투자 증가 등 여러 요인에 의해 주도되고 있습니다. 주요 성장 요인 중 하나는 노인 인구의 증가로 장기적인 치료가 필요한 만성 질환의 유병률이 증가하고 있다는 점입니다. 제약사들은 고령 환자의 특수한 니즈에 대응하기 위해 보다 표적화된 치료법과 혁신적인 약물전달 시스템을 개발하여 대응하고 있습니다. 또한, 바이오테크놀러지와 개인 맞춤형 의료의 발전은 더 효과적이고 부작용이 적은 의약품을 개발할 수 있는 새로운 길을 열어주고 있습니다. 특히 개발도상국에서는 더 많은 사람들이 더 쉽게 의료 서비스를 받을 수 있도록 의료 인프라 구축에 힘쓰고 있습니다. 또한, 정부와 의료 기관은 예방 의료와 노인의 만성 질환 관리에 더 많은 관심을 기울이고 있으며, 이는 특수 의약품에 대한 수요를 더욱 증가시키고 있습니다. 이러한 요인들은 노인 건강 문제에 대한 사람들의 인식이 높아지면서 세계 노인용 의약품 시장의 지속적인 성장에 기여하고 있습니다.

조사 대상 기업 예시(총 52건)

  • AbbVie, Inc.
  • Adare Pharma Solutions
  • Akums Drugs & Pharmaceuticals Ltd.
  • Bausch Health Companies Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Endo Pharmaceuticals, Inc.
  • Ferring International Center SA
  • Fortis Healthcare Ltd.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 24.10.29

Global Geriatric Medicines Market to Reach US$222.5 Billion by 2030

The global market for Geriatric Medicines estimated at US$153.2 Billion in the year 2023, is expected to reach US$222.5 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Antihypertensive Therapeutics, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$49.9 Billion by the end of the analysis period. Growth in the Analgesics Therapeutics segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$41.7 Billion While China is Forecast to Grow at 9.1% CAGR

The Geriatric Medicines market in the U.S. is estimated at US$41.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$47.2 Billion by the year 2030 trailing a CAGR of 9.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Geriatric Medicines Market - Key Trends & Drivers Summarized

What Are Geriatric Medicines, and Why Are They Vital for an Aging Population?

Geriatric medicines are specialized drugs designed to address the unique health challenges faced by elderly patients. As people age, they often encounter multiple health issues, including chronic conditions like hypertension, diabetes, arthritis, and cognitive disorders, requiring a multidisciplinary approach to treatment. Geriatric medicines cater specifically to this demographic, focusing on conditions that are prevalent in older adults and providing therapies that are more appropriate for their physiological and metabolic needs. These medicines not only address disease management but also improve the overall quality of life for aging individuals by ensuring that treatment minimizes side effects and interactions with other medications. With the global population aging rapidly, especially in developed countries, the demand for geriatric medicines continues to grow, making it a crucial sector within the healthcare industry.

How Are Advances in Pharmaceuticals Shaping Geriatric Medicine Development?

Advances in pharmaceutical research and development are having a profound impact on the creation of more effective and safer geriatric medicines. One major area of innovation is the development of personalized medications that are tailored to the specific needs of elderly patients, taking into account their unique health conditions and the polypharmacy issues often associated with aging. Slow-release drug formulations, combination therapies, and easier-to-administer medications, such as patches and dissolvable tablets, are being developed to address compliance challenges that older adults face. Furthermore, biotechnology is playing a key role in creating targeted therapies for conditions such as Alzheimer’s, osteoporosis, and cardiovascular diseases, which are more prevalent in the geriatric population. These advancements not only improve treatment outcomes but also reduce the risk of drug interactions and side effects, ensuring that older adults can manage their conditions more effectively.

Why Are Changing Demographics and Healthcare Systems Driving Demand for Geriatric Medicines?

The aging global population is a significant driver of the demand for geriatric medicines. As life expectancy increases, the proportion of elderly individuals is growing rapidly, particularly in regions like North America, Europe, and East Asia. This demographic shift is creating an urgent need for healthcare systems to adapt and provide adequate medical care for older adults. Governments and healthcare providers are investing more in geriatric healthcare, with a focus on preventive care and the management of age-related chronic diseases. Additionally, as healthcare infrastructure improves in emerging markets, access to geriatric care is expanding, further fueling demand for specialized medicines. Public awareness of age-related health conditions is also increasing, leading to greater demand for early diagnosis and treatment options for conditions such as dementia, arthritis, and cardiovascular diseases. This growing focus on elderly care is transforming the healthcare landscape and making geriatric medicine a priority for healthcare providers and pharmaceutical companies alike.

What Is Driving the Growth of the Global Geriatric Medicines Market?

The growth in the global geriatric medicines market is driven by several factors, including advancements in drug development, an aging global population, and increased healthcare investment. One of the key growth drivers is the expanding elderly population, which is leading to a higher prevalence of chronic diseases that require long-term medical treatment. Pharmaceutical companies are responding by developing more targeted therapies and innovative drug delivery systems that cater to the specific needs of geriatric patients. Additionally, advancements in biotechnology and personalized medicine are opening new avenues for creating drugs that are more effective and have fewer side effects. The increasing focus on healthcare infrastructure improvements, especially in developing countries, is making geriatric medicines more accessible to a broader population. Furthermore, governments and healthcare organizations are placing a greater emphasis on preventive care and chronic disease management for the elderly, further driving the demand for specialized medicines. These factors, combined with growing public awareness of geriatric health issues, are contributing to the sustained growth of the global geriatric medicines market.

Select Competitors (Total 52 Featured) -

  • AbbVie, Inc.
  • Adare Pharma Solutions
  • Akums Drugs & Pharmaceuticals Ltd.
  • Bausch Health Companies Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Endo Pharmaceuticals, Inc.
  • Ferring International Center SA
  • Fortis Healthcare Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Geriatric Medicines - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Aging Population Throws Spotlight on the Increasing Demand for Geriatric Medicines
    • Increasing Prevalence of Age-Related Chronic Conditions Spurs Significant Growth in the Market for Geriatric Medicines
    • Technological Advancements in Drug Delivery Systems Strengthen the Business Case for Specialized Geriatric Formulations
    • Expansion of Elderly Healthcare Programs Expands Addressable Market for Geriatric Medicines Across Healthcare Systems
    • Growing Awareness of Preventive Healthcare and Early Intervention Propels Demand for Geriatric Medicines Focused on Disease Prevention
    • Increasing Focus on Personalized Medicine Drives Adoption of Tailored Geriatric Drug Regimens Based on Individual Health Profiles
    • Rising Incidence of Polypharmacy in the Elderly Generates Demand for Safer and More Compatible Geriatric Medicines
    • Shift Toward Home Healthcare and Telemedicine Expands Opportunities for Remote Monitoring of Geriatric Drug Therapies
    • Growing Popularity of Over-the-Counter (OTC) Geriatric Supplements Strengthens Market for Preventive Geriatric Healthcare
    • Increased Research and Development in Age-Related Diseases Drives Growth in Geriatric Medicines Targeting Dementia, Arthritis, and Cardiovascular Issues
    • Rising Focus on Palliative Care and Pain Management Expands the Market for Geriatric Medicines That Improve Quality of Life
    • Increased Use of Biotechnology and Gene Therapy Generates New Opportunities for Innovative Geriatric Medicines
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Geriatric Medicines Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Geriatric Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Geriatric Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Geriatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Antihypertensive Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Antihypertensive Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Antihypertensive Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Analgesics Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Analgesics Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Analgesics Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Antidiabetic Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Antidiabetic Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Antidiabetic Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Anticoagulant Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Anticoagulant Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Anticoagulant Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Statins Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Statins Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Statins Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Proton Pump Inhibitors Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Proton Pump Inhibitors Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Proton Pump Inhibitors Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Antipsychotic Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Antipsychotic Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Antipsychotic Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Therapeutic Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Therapeutic Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Therapeutic Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • JAPAN
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • CHINA
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • EUROPE
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Geriatric Medicines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Geriatric Medicines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Geriatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • FRANCE
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • GERMANY
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Geriatric Medicines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Geriatric Medicines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Geriatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • INDIA
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 128: India Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: India 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 131: India Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: India 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Geriatric Medicines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Geriatric Medicines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Geriatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Geriatric Medicines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Geriatric Medicines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Geriatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • AFRICA
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제